1qd3
From Proteopedia
Line 1: | Line 1: | ||
[[Image:1qd3.gif|left|200px]] | [[Image:1qd3.gif|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_1qd3", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | | | + | or leave the SCENE parameter empty for the default display. |
- | | | + | --> |
- | + | {{STRUCTURE_1qd3| PDB=1qd3 | SCENE= }} | |
- | + | ||
- | + | ||
- | }} | + | |
'''HIV-1 TAR RNA/NEOMYCIN B COMPLEX''' | '''HIV-1 TAR RNA/NEOMYCIN B COMPLEX''' | ||
Line 19: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
- | + | Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1QD3 OCA]. | |
==Reference== | ==Reference== | ||
Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B., Faber C, Sticht H, Schweimer K, Rosch P, J Biol Chem. 2000 Jul 7;275(27):20660-6. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/10747964 10747964] | Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B., Faber C, Sticht H, Schweimer K, Rosch P, J Biol Chem. 2000 Jul 7;275(27):20660-6. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/10747964 10747964] | ||
- | [[Category: Human immunodeficiency virus 1]] | ||
- | [[Category: Protein complex]] | ||
[[Category: Faber, C.]] | [[Category: Faber, C.]] | ||
[[Category: Roesch, P.]] | [[Category: Roesch, P.]] | ||
[[Category: Sticht, H.]] | [[Category: Sticht, H.]] | ||
- | [[Category: | + | [[Category: Aminoglycoside-rna-complex]] |
- | [[Category: | + | [[Category: Hiv-1]] |
- | [[Category: | + | [[Category: Minor groove binding]] |
- | [[Category: | + | [[Category: Nmr]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 06:08:51 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 03:08, 3 May 2008
HIV-1 TAR RNA/NEOMYCIN B COMPLEX
Overview
Binding of human immunodeficiency virus type 1 (HIV-1) transactivator (Tat) protein to Tat-responsive RNA (TAR) is essential for viral replication and is considered a promising starting point for the design of anti-HIV drugs. NMR spectroscopy indicated that the aminoglycosides neomycin B and ribostamycin bind to TAR and that neomycin is able to inhibit Tat binding to TAR. The solution structure of the neomycin-bound TAR has been determined by NMR spectroscopy. Chemical shift mapping and intermolecular nuclear Overhauser effects define the binding region of the aminoglycosides on TAR and give strong evidence for minor groove binding. Based on 15 nuclear Overhauser effect-derived intermolecular distance restraints, a model structure of the TAR-neomycin complex was calculated. Neomycin is bound in a binding pocket formed by the minor groove of the lower stem and the uridine-rich bulge of TAR, which adopts a conformation different from those known. The neamine core of the aminoglycoside (rings I and II) is covered with the bulge, explaining the inhibition of Tat by an allosteric mechanism. Neomycin reduces the volume of the major groove in which Tat is bound and thus impedes essential protein-RNA contacts.
About this Structure
Full crystallographic information is available from OCA.
Reference
Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B., Faber C, Sticht H, Schweimer K, Rosch P, J Biol Chem. 2000 Jul 7;275(27):20660-6. PMID:10747964 Page seeded by OCA on Sat May 3 06:08:51 2008